RGEN Q2 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$48M+47.1% YoY

Gross Profit

$27M55.8% margin

Operating Income

$4M9.0% margin

Net Income

$3M5.7% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$745M

Total Liabilities

$146M

Stockholders' Equity

$599M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$32M	+47.1%
Gross Profit	$27M	$19M	+43.9%
Operating Income	$4M	$5M	-21.9%
Net Income	$3M	$8M	-67.6%

Revenue Segments

Product

$48M100%

Geographic Segments

North America

$22M47%

Europe

$20M41%

Asia and Australia

$6M12%

All Other

$55,0000%